Central dogma in thyroid dysfunction: A review on structure modification of TSHR as a cornerstone for thyroid abnormalities

Pakistan Journal of Biological Sciences

Volumn 14, Issue 3, 2011, Pages 170-181

  Mansourian, Azad Reza ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alteration; Hyperthyroidism; Hypothyroidism; Mutation; Receptor

Indexed keywords

THYROTROPIN; THYROTROPIN RECEPTOR;

CHEMISTRY; FEMALE; GENETICS; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PROTEIN QUATERNARY STRUCTURE; REVIEW; THYROID DISEASE;

FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MUTATION; PREGNANCY; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, THYROTROPIN; THYROID DISEASES; THYROTROPIN;

EID: 79957471905     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.170.181     Document Type: Review

References (136)

1. Abramowicz, M.J., L. Duprez, J. Parma, G. Vassart and C. Heinrichs, 1997. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J. Clin. Invest., 99: 3018-3024.
2. Akamizu, T., D. Inoue, S. Kosugi, L.D. Kohn and T. Mori, 1994. Further studies of amino acids (268-304) in thyrotropin (TSH)-lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: Cysteine-301 is important in TSH binding and receptor tertiary structure. Thyroid., 4: 43-48.
3. Alberti, L., M.C. Proverbio, S. Costagliola, G. Weber, P. Beck-Peccoz, G. Chiumello and L. Persani, 2001. A novel germline mutation in the TSH receptor gene causes nonautoimmune autosomal dominant hyperthyroidism. Eur. J. Endocrinol., 145: 249-254.
4. Alberti, L., M.C. Proverbio, S. Costagliola, S.R. Romoli and B. Boldrighini et al., 2002. Germlinemutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J. Clin. Endocrinol. Metab., 87: 2549-2555.
5. Amino, N., Y. Watanabe, H. Tamaki, Y. Iwatani and K. Miyai, 1987. In vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies. Clin. Endocrinol., 27: 615-624.
6. Ando, T., R. Latif and T.F. Davies, 2005. Review thyrotropin receptor antibodies: New insights into their actions and clinical relevance. Best Pract. Res. Clin. Endocrinol. Metab., 19: 33-52.
7. Aoshima, H., T. Yoshida, S. Kobayashi, Y. Mizushima and S. Kawai, 2000. Genomic DNA analysis of thyrotropin receptor in a family with hereditary hyperthyroidism. Endocr. J., 47: 365-372.
8. Biebermann, H., T. Schoneberg, H. Krude, G. Schultz, T. Gudermann and A. Gruters, 1997. Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J. Clin. Endocrinol. Metab., 82: 3471-3480.
9. Biebermann, H., T. Schoneberg, C. Hess, J. Germak, T. Gudermann and A. Gruters, 2001. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J. Clin. Endocrinol. Metab., 86: 4429-4433.
10. Burrow, G.N., 1993. Thyroid function and hyperfunction during gestation. Endocrinol. Rev., 14: 194-202.
11. Calebiro, D., T. de Filippis, S. Lucchi, C. Covino and L. Persani et al., 2005. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum. Mol. Genet., 14: 2991-3002.
12. Chazenbalk, G.D. and B. Rapoport, 1995. Expression of the extracellular region of the thyrotropin receptor in a baculovirus vector using a promoter active earlier than the polyhedrin promoter: Implications for the expression of functional, highly glycosylated proteins. J. Biol. Chem., 270: 1543-1549.
13. Chazenbalk, G.D., A. Kakinuma, J.C. Jaume, S.M. McLachlan and B. Rapoport, 1996. Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology, 137: 4586-4591.
14. Chazenbalk, G.D., K. Tanaka, Y. Nagayama, A. Kakinuma, J.C. Jaume, S.M. McLachlan and B. Rapoport, 1997. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology, 138: 2893-2899.
15. Christensen, V.L. and G.S. Davis, 2004. Maternal dietary iodide influences turkey embryo thyroid function. Int. J. Poult. Sci., 3: 550-557.
16. Couet, J., S. Sar, A. Jolivet, M.T. VuHai, E. Milgrom and M. Misrahi, 1996. Shedding of human thyrotropin receptor ectodomain: Involvement of a matrix metalloprotease. J. Biol. Chem., 271: 4545-4552.
17. De Roux, N., M. Misrahi, R. Brauner, M. Houang and J.C. Carel et al., 1996. Four families with loss of function mutations of the thyrotropin receptor. J. Clin. Endocrinol. Metab., 81: 4229-4235.
18. Da Costa, C.R. and A.P. Johnstone, 1998. Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies. J. Biol. Chem., 273: 11874-11880.
19. De Bernard, S., M. Misrahi, J.C. Huet, I. Beau and E. Milgrom etal, 1999. Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J. Biol. Chem., 274: 101-107.
20. Dias, J.A., 1996. Human follitropin heterodimerization and receptor binding structural motifs: Identification and analysis by a combination of synthetic peptide and mutagenesis approaches. Mol. Cell. Endocrinol., 125: 45-54.
21. Duprez, L., J. Parma, S. Costagliola, J. Hermans, J. van Sande, J.E. Dumont and G. Vassart, 1997. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBSLett, 409: 469-474.
22. Duprez, L., J. Parma, J. Van Sande, P. Rodien and G. Vassart et al, 1999. Pathology of the TSH receptor. J. Pediatr. Endocrinol. Metab., 12: 195-302.
23. Eftekhari, M.H., Z. Mazloom, A. Ahmadi and H.M. Khosravi, 2007. Body mass index and throid function in adolescenct girls. Pak. J. Biol. Sci., 10: 905-909.
24. Esapa, C.T., L. Duprez, M. Ludgate, M.S. Mustafa, P. Kendall-Taylor, G. Vassart and P.E. Harris, 1999. A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid., 9: 1005-1010.
25. Eschler, D.C., A. Hasham and Y. Tomer, 2011. Cutting Edge: The etiology of autoimmune thyroid diseases. Clin. Rev. Allergy Immunol.,
26. Farid, N.R., V. Kascur and C. Balazs, 2000. The human thyrotropin receptor is highly mutable: A review of gain-of-function mutations. Eur. J. Endocrinol., 143: 25-30.
27. Fiedler, K. and K. Simons, 1995. The role of N-Glycans in the secretory pathway. Cell, 81: 309-312.
28. + channels. Lett. Peptide Sci., 4: 305-312.
29. Fuhrer, D., H.P. Holzapfel, P. Wonerow, W.A. Scherbaum and R. Paschke, 1997a. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in31 toxic thyroid nodules. J. Clin. Endocrinol. Metab., 82: 3885-3891.
30. Fuhrer, D., P. Wonerow, H. Willgerodt and R. Paschke, 1997b. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J. Clin. Endocrinol. Metab., 82: 4234-4238.
31. Fuhrer, D., J. Warner, M. Sequerira, R. Paschke, J. Gregory and M. Ludgate, 2000. TSHR germline mutation (Met463Val) masquerading as Graves disease in a large Welsh kindred with hyperthyroidism. Thyroid., 10: 1035-1041.
32. Gagne, N., J. Parma, C. Deal, G. Vassar and G. van Vliet, 1998. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: Are athyreosis and ectopic thyroid distinct entities. J. Clin. Endocrinol. Metab., 83: 1771-1775.
33. Golinor, D., 1997. The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocrine Rev., 18: 404-433.
34. Goodwin, T.M., M. Montoro, J.H. Mestman, A.E. Pekary and J.M. Hershman, 1992. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J. Clin. Endocrinol. Metab., 75: 1333-1337.
35. Goretzki, P.E., J. Lyons, S. Stacy Phipps, W. Rosenau and M. Demeure et al., 1992. Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J. Surg., 16: 576-581.
36. Grasberger, H., A. Mimouni-Bloch, M.C. Vantyghem, G. van Vliet and M. Bramowicz et al., 2005a. Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: Clinical characterization and exclusion of candidate loci. J. Clin. Endocrinol. Metab., 90: 4025-4034.
37. Grasberger, H., M.M. Vaxillaire, S. Pannain, J.C. Beck and A. Mimouni-Bloch et al., 2005b. Identification of a locus for nongoitrous congenital hypothyroidism on chromosome 15q25.3-26.1. Hum. Genet, 118: 348-355.
38. Grossmann, M., B.D. Weintraub and M.W. Szkudlinski, 1997. Novel insights into the molecular mechanisms of human thyrotropin action: Structural, physiological and therapeutic implications for the glycoprotein hormone family. Endocr. Rev., 18: 476-501.
39. Gruters, A., T. Schoneberg, H. Biebermann, H. Krude, H.P. Krohn, H. Dralle and T. Gudermann, 1998. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J. Clin. Endocrinol. Metab., 83: 1431-1436.
40. Guerra, M.M. and E.M. Rodriguez, 2009. Expression of tuberalin II, a-subunit of glycoprotein hormones and a-thyrotropin hormone in the pars tuberalis of the rat: Immunocytochemical evidence for pars tuberalis-specific cell types. Neuroendocrinology, 90: 269-282.
41. Hamidi, S., C.R. Chen, Y. Mizutori-Sasai, S.M. Mclachan and B. Rapoport, 2011. Relationship between thyrotropin receptor hinge region proteolytic posttranslational modification and receptor physiological function. Mol. Endocrinol., 25: 184-194.
42. Hebrant, A., W.C. van Staveren, C. Maenhaut, J.E. Dumont and J. Leclere, 2011. Genetic hyperthyroidism: Hyperthyroidism due to activating TSHR mutations. Eur. J. Endocrinol, 164: 1-9.
43. Holzapfel, H.P., P. Wonerow, W. von Petrykowski, M. Henschen, W.A. Scherbaum and R. Paschke, 1997. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J. Clin. Endocrinol. Metab., 82: 3879-3884.
44. Hunt N., K.P. Willey, D. Jahner, R. Ivell, W. Northemann, M.A. Castel and F. Leidenberger, 1992. Multiple forms of thyroid stimulating hormone receptor associated with Graves disease. Exp. Clin. Endocrinol, 100: 22-27.
45. Kaczur, V., L.G. Puskas, Z.U. Nagy, N. Miled and A. Rebai et al, 2007. Cleavage of the human thyrotropin receptor by AD AMI 0 is regulated by thyrotropin. J. Mol. Recognition, 20: 392-404.
46. Kajava, A.V., G. Vassart and S. J. Wodak, 1995. Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure, 3: 867-877.
47. Kajita, Y., C.R. Rickards, P.R. Buckland, R.D. Howells and B. Rees Smith, 1995. Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem. J., 227: 413-420.
48. Karges, B., G. Krause, J. Homoki, K.M. Debatin, N. De Roux and W. Karges, 2005. TSH 6 receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J. Endocrinol, 186: 377-385.
49. Khoo, D.H., J. Parma, C. Rajasoorya, S.C. Ho and G. Vassart, 1999. A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J. Clin Endocrinol. Metab., 84: 1459-1462.
50. Kohler, B., H. Biebermann, H.P. Krohn, D. Dralle, R Finke and A. Gruters, 1996. A novel germline mutation in the TSH receptor gene causing nonautoimmune congenital hyperthyroidism. Int. Congress Endocrinol, 946: 641-641.
51. Kopp, P., J. van Sande, L. Parma, K. Duprez, J.L. Zuppinger and G. Vassart, 1995. Congenital non-autoimmune hyperthyroidism caused by a neomutation in the thyrotropin receptor gene. New Engl. J. Med., 332: 150-154.
52. Kopp, P., J.L. Jameson and T.F. Roe, 1997a. Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid., 7: 765-770.
53. Kopp, P., S. Mmrhead, N. Jourdain, W.X. Gu, J.L. Jameson and C. Rodd, 1997b. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation(serine281~>isoleucine) in the extracellular domain of the thyrotropin receptor. J. Clin. Invest, 100: 1634-1639.
54. Kosugi, S. and T. Mori, 1995. TSH receptor and LH receptor, 1995. Endocrine J., 42: 587-606.
55. Kosugi, S., H. Sugawa and T. Mori, 1996. TSH receptor andLH receptor. Endocrine J., 43: 595-604.
56. Kosugi, S., 2002. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor] Nippon Rmsho, 60: 291-296.
57. Kraemer, S., K. Rothe, R. Pfaeffle, D. Fuehrer-Sakel, H. Till and O.J. Muensterer, 2009. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy. J. Pediatr. Endocrinol. Metab., 22: 269-274.
58. Lado-Abeal, J., L.R. Quisenberry and I. Castro-Piedras, 2010. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations. Methods Enzymol., 484: 375-395.
59. Lado-Abeal, J., I. Castro-Piedras, F. Palos-Paz, J.I. Labarta-Aizpun and R. Albero-Gamboa, 2011. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G a-protein subunit genes. Thyroid, 21: 103-109.
60. Latif, R, K. Michalk, S.A. Morshed and T.F. Davis, 2010a. A Tyrosine residue on the TSH receptor stabilizews multimer formation. PloS One, 5: e9449-e9449.
61. Latif, R., K. Michalek and T.F. Davies, 2010b. Subunit interactions influence TSHR multimerization. Mol. Endocrinol, 24: 2009-2018.
62. Latif, R., T. Ando and T.F. Davies, 2007. Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation. Endocrinology, 148: 3164-3175.
63. Lee, Y.S., L. Poh and K.Y. Loke, 2002. An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism. J. Pediatr. Endocrinol. Metab., 15: 211-215.
64. Leitolf, H., K.P.T. Tong, M. Grossmann, B.D. Wemtraub and M.W. Szkudlinski, 2000. Bioengineering of human thyrotropin superactive analogs by site-directed lysine-scanning mutagenesis: Cooperative effects between peripheral loops. J. Biol. Chem., 275: 27457-27465.
65. Li, Q., G. Yang, Y. Wang, X. Zhang and Q. Sang et ed., 2011. Common genetic variation in the 3'-untranslated region of gonadotropin-re leasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients. Hum. Genet.
66. Loosfelt, H., C. Pichon, A. Jolivet, M. Misrahi and B. Caillou et at, 1992. Two-subunit structure of the human thyrotropin receptor. Proc. Natl. Acad. Sci. USA., 89: 3765-3769.
67. Lowman, H.B. and J. A. Wells, 1993. Affinity maturation of human growth hormone by monovalent phage display. J. Mol. Biol, 234: 564-578.
68. Lyons, J., C.A. Landis, G. Harsh, L. Vallar and K. Grunewald etal, 1990. Two G protein oncogenes inhuman endocrine tumors. Science, 249: 655-659.
69. Maier, J., H. van Steeg, C. van Oostrom, S. Karger, R. Paschke and K. Krohn, 2006. Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology, 147: 3391-3397.
70. Maiti, M., K. Sen, S. Sen and S. Lahiri, 2011. Studies on stabilities of some human chorionic gonadotropin complexes with a-emitting radionuclides. Applied Radiation Isotopes, 69: 316-319.
71. Mansourian, A.R., E.O. Ghaemi, A.R. Ahmadi, A. Saifi, A.V. Moradi and S. Bakhshandehnosrat, 2007. A survy of urinary iodine concentration in South East of Northern Iran. Pak. J. Biol Sci., 10: 2166-2171.
72. Mansourian, A.R., E. Ghaemi, A.R. Ahmadi, A. Marjani, A. Saifi and S. Bakhshandehnosrat, 2008. Serum lipid level alteration in sub clinical hypothyroid patients in Gorgan(South east Caspian Sea), L. Chinese Clin. Med., 3: 206-210.
73. Mansourian, A.R., A.R. Ahmadi, A. Saifi and S. Bakhshandehnosrat, 2010a. The children reference range of thyroid hormones in Northern Iran. Pak. J. Biol. Sci., 13: 862-865.
74. Mansourian, A.R., A.R. Ahmadi, H.R Mansourian, A. Sifi, A. Marjani and E. Ghaemi, 2010b. Maternal thyroid stimulating hormone level during the first trimester of pregnancy at South East of Caspian sea in Iran. J. Clin. Diagnostic Res., 4: 2472-2477.
75. Mansourian, A.R., 2010a. A review on post-puberty hypothyroidism: Agalance at myxedema. Pak. J. Biol. Sci., 13: 866-876.
76. Mansourian, A.R., 2010b. Metabolic pathways of tetraidothyronine(T4) and triidothyronin(T3) production by thyroid gland: A review of articles. Pak. J. Biol. Sci., 14: 1-12.
77. Mansourian, A.R., 2010c. Thyroid function tests during first-trimester of pregnancy: A reviewof Litrature. Pak. J. Biol. Sci., 13: 664-673.
78. Mansourian, A.R., 2010d. The immune system which adversely alter thyroid functions: A review on the concept of autoimmunity. Pak. J. Biol. Sci., 13: 765-774.
79. Mansourian, A.R., 2010e. A review on hyperthyroidism: Thyrotoxicosis under surveillance. Pak. J. Biol. Sci., 13: 1066-1076.
80. Mansourian, A.R. and A.R. Ahmadi, 2010. Correlation between inverse age and serum thyroxine level among children and adolescents. J. Clin. Diagnostic Res., 4: 3196-3200.
81. Marjani, A., A.R. Mansourian, E.O. Ghaemi, A. Aahmadi and V. Khori, 2008. Lipidperoxidation in serum ofhypothyroidpatients in Gorgan-South Eastof Caspian Sea. Asian J. Cell Biol, 3: 47-50.
82. Misarhi, M., N. Ghinea, S. Sar, B. Saunier and A. Jolivete, 1994. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur. J. Biochem., 222: 711-719.
83. Miyai, S., S. Yoshimura, Y. Iwasaki, S. Takekoshi, R. V. Lloyd and R. Y. Osamura, 2005. Induction of GH, PRL and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line. Cell Tissue Res., 322: 269-277.
84. Moodley, K., J. Botha, D.M. Raidoo and S. Naidoo, 2010. Immuno-localisation of anti-thyroid antibodies in adult human cerebral cortex. J. Neurol. Sci., 10.1016/j.jns.2010.11.027
85. Morgenthaler, N.G., W.B. Minich, M. Willinch, T. Bogusch and J.M. Hollidt et at., 2003. Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum. Mol. Cell. Endocrinol, 212: 73-79.
86. Murakami, M., K. Miyashita, M. Yamada, T. Iriuchijima and M. Mori, 1992. Characterization of human thyrotropin receptor-related peptide-like immunoreactivity in peripheral blood of Graves disease. Biochem. Biophys. Res. Commun, 186: 1074-1080.
87. Nakabayashi, K., M. Kudo, B. Kobilka and A.J. Hsueh, 2000. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J. Biol. Chem., 275: 30264-30271.
88. Nebel, I.T., B. Trultsch and R. Paschke, 1999. TSH receptor mutation database. J. Endocrinol. Metab., 84: 2263-2263.
89. Neumann, S., B.M. Raaka and M.C. Gershengorn, 2010. Contitutivity active thyrotropin and throtropin -releasing hormone receptors and their inverse agonists. Methods Enzymol., 485: 147-160.
90. NunezMiguel, R, J. Sanders, D.Y. Chirgadze, J. Furmaniak and B.R. Smith, 2009. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: A comparative structural study of protein-protein interactions. J. Mol. Endocrinol, 42: 381-395.
91. Nurwakagari, P., A. Breiti, C. Hess, H. Salman-Livny, D. Ben-Menahem and T. Gudermann, 2007. A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation. J. Mol. Endocrinol, 38: 259-275.
92. Oda, Y., J. Sanders, M. Evans, A. Kiddie and A. Munkley et al., 2000. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid., 10: 1051-1059.
93. Osuga, Y., M. Hayashi, M. Kudo, M. Conti, B. Kobilka and A.J. Hsueh, 1997. Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J. Biol Chem., 272: 25006-25012.
94. O'Sullivan, C, CM. Barton, S.L. Staddon, C.L. Brown and N.R. Lemoine, 1991. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol. Carcmog., 4: 345-349.
95. Palczewski, K., T. Kumasaka, T. Hori, C.A. Behnke and H. Motoshima et al., 2000. Crystal structure of rhodopsin: A G protein-coupled receptor. Sci., 289: 739-745.
96. Palos-Paz, F., O. Perez-Guerra, J. Cameselle-Teijeiro, C. Rueda-Chimeno and F. Barreiro-Morandeira et al., 2008. Prevalence of mutations in TSHR, GNAS, PRKARIA and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spam. Eur. J. Endocrinol, 159: 623-631.
97. Parma, J., J. van Sande, S. Swillens, M. Tonacchera, J. Dumont and G. Vassart, 1995. Monophosphate and inositol phosphate-Ca2+ cascades. Mol. Endocrinol., 9: 725-733.
98. Parma, J., L. Duprez, J. van Sande, G. Hermans and G. van Vlietx, 1997. Diversity and prevalence of somatic mutations adenomas in the TSH receptor and Gs a genes as a cause of toxic thyroid Adenomas. J. Clin. Endocrinol. Metab., 82: 2695-2701.
99. Paschke, R., J. van Sande, J. Parma and G. Vassart, 1996. The TSH receptor and thyroid diseases. Clin. Endocrinol. Metab., 10: 9-27.
100. Picchietti, S., M. Belardinelli, A.R. Taddei, A.M. Fausto and M. Pellegrino et al., 2009. Thyroid disruptor l,l,l-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) prevents internalization of TSH receptor. Cell. Tissue Res., 336: 31-40.
101. Richert, N.D. and R.J. Ryan, 1997. Proteolytic enzyme activation of rat ovarian adenylate cyclase. Proc. Natl. Acad. Sci. USA., 74: 4857-4861.
102. Rodien, P., C. Bremont, M.L. Sanson, J. Parma and J. van Sande et al., 1998. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N. Engl. J. Med., 339: 1823-1826.
103. Rudajev, V., J. Novotny, L. Hejnova, G. Milligan and P. Svoboda, 2005. Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and Gqalpha/Gl 1 alpha protein. J. Biochem., 138: 111-125.
104. Russo, D., G.D. Chazenbalk, Y. Nagayama, H.L. Wadsworth, P. Seto and B. Rapoport, 1991. A new structural model for the thyrotropin (TSH) receptor as determined by covalent crosslinking of TSH to the recombinant receptor in intact cells: Evidence for a single polypeptide chain. Mol. Endocrinol, 5: 1607-1612.
105. Russo, D., Y. Nagayama, G.D. Chazenbalk, H.L. Wadsworth and B. Rapoport, 1992. Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor. Endocrinology, 130: 2135-2138.
106. Russo, D., F. Arturi, R. Wicker, G.D. Chazenbalk and M. Schlumberger et al., 1995. Genetic alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol. Metab., 80: 1347-1351.
107. Russo, D., F. Arturi, E. Chiefari and S. Filetti, 1997. Molecular insights into TSH receptor abnormality and thyroid disease. J. Endocrinol. Invest., 20: 36-47.
108. Russo, D., C. Betterle, F. Arturi, E. Chiefari, M.E. Girelh and S. Filetti, 2000. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. J. Clin. Endocrinol. Metab., 85: 4238-4242.
109. Saber, A.P.R., M.T. Jalali, D. Mohjen, A.A. Akhoole, H.Z.N. Teymourluei, M. Nouri and S. Garachorlo, 2009. The effect of ambient temperature on thyroid hormones concentration and histopathologic al changes of thyroid gland in cattle in Tabriz, Iran. Asian J. Anim. Vet. Adv., 4: 28-33.
110. Sanders, J., D.Y. Chirgadze, P. Sanders, S. Baker and A. Sullivanx 2007. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid, 17: 395-410.
111. Sanders, J., R.N. Miguel, J. Furmaniak and B.R. Smith, 2010. TSH receptor monoclonal antibodies with agonist, antagonist and inverse agonist activities. Methods Enzymol, 485: 393-420.
112. Sanders, P., S. Young, J. Sanders, K. Kabelis and S. Baker et al, 2011. Crystal structure of the TSH receptor bound to a blocking type TSHR autoantibody. J. Mol. Endocrinol., 10.1530/JME-10-0127
113. Schreiber, G. and A.R. Fersht, 1993. Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering. Biochemistry, 32: 5145-5150.
114. Seetharamaiah, G.S., A. Kurosky, R.K. Desai, J.S. Dallas and B.S. Prabhakar, 1994. A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. Endocrinology, 134: 549-554.
115. Shahmohammdi, F., A.R. Mansourian and H.R Mansourian, 2008. Serum thyroid hormone level in women with nausea and vomiting in early pregnancy. J. Med. Sci., 8: 507-510.
116. Smith, B.R., J. Sanders and J. Furmaniak, 2007. Review TSH receptor antibodies. Thyroid, 17: 923-938.
117. Suarez, H.G., J.A. du Villard, B. Caillou, M. Schlumberger, C. Parmentier and R. Monier, 1991. Gsp mutations in human thyroid tumours. Oncogene, 6: 677-679.
118. Swammathan, R., R.K. Chin, T.T.H. Lao, Y.T. Mak, N.S. Panesar and C.S. Cochram, 1989. Thyroid function in hyperemesis gravidarum. Acta Endocrinol, 120: 155-160.
119. Takeshita, A., Y. Nagayama, N. Yokoyama, K. Ishikawa and K. Ito et al., 1995. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J. Clin. Endocrinol. Metab., 80: 2607-2611.
120. Thomas, J.S., J. Leclere, P. Hartemann, J. Duheille and J.C. Guedenet et al., 1982. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol. Copenh., 100: 512-518.
121. Tomer, Y., 2010. Genetic susceptibility to autoimmune thyroid disease: Past, present and future. Thyroid, 20: 715-725.
122. Tonacchera, M., J. Van Sande, F. Cetani, S. Swillens and C. Schvartz et al., 1996. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J. Clin. Endocrinol. Metab., 81: 547-554.
123. Tonacchera, M., P. V itti, P. Agretti, B. Giulianetti and B. Mazzi etal., 1998a. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid., 8: 559-564.
124. Tonacchera, M., L. Chiovato, A. Pinchera, P. Agretti and E. Fiore et al, 1998b. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J. Clin. Endocrinol. Meta., 83: 492-498.
125. Tonacchera, M., P. Agretti, L. Chiovato, V. Rosellini and G. Ceccarini et al, 2000. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J. Clin. Endocrinol. Metab., 85: 2270-2274.
126. Van Sande, J., J. Parma, M. Tonacchera, S. Swillens, J. Dumont and G. Vassart, 1995a. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J. Clin. Endocrinol. Metab., 80: 2577-2585.
127. Van Sande, J., S. Swillens, C. Gerard, A. Allgeier, C. Massart, G. Vassart and J. Dumont, 1995b. In Chinese hamster ovary Kl cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bis phosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence. Eur. J. Biochem., 229: 338-343.
128. Vanvooren, V., S. Uchino, L. Duprez, M.J. Costa and J. Vandekerckhove etal., 2002. Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur. J. Endocrinol, 147: 287-291.
129. Vassart, G. and J.E. Dumont, 1992. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev., 13: 596-611.
130. Vern, L.C., D.T. Ort and J.L. Grimes, 2003. Physiological factors associated with weak neonatal poults (Meleagris gallopavo). Int. J. Poult. Sci., 2: 7-14.
131. Wadsworth, H.L., G.D. Chazenbalk, Y. Nagayama, D. Russo and B. Rapoport, 1990. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science, 249: 1423-1425.
132. Wang, Y., B.J. Shen and W. Sebald, 1997. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. Proc. Natl. Acad. Sci. USA., 94: 1657-1662.
133. Xie, J., S. Pannain, J. Pohlenz, R.E. Weiss and K. Moltz et al, 1997. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J. Clin. Endocrinol. Metab., 82: 3933-3940.
134. Zarei, M.A., A. Farshad and S. Akhondzadeh, 2009. Variation in thyroidal activity during estrous cycle and natural breeding season in markhos goat breeds. Pak. J. Biol. Sci., 12: 1420-1424.
135. Zhang, S.B., B. Dattatreyamurty and L.E. Jr. Reichert, 1988. Regulation of follicle-stimulating hormone binding to receptors on bovine calf testis membranes by cholera toxin-sensitive guanine nucleotide binding protein. Mol. Endocrinol., 2: 148-158.
136. Zhang, M.L., H. Sugawa, S. Kosugi and T. Mori, 1995. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem. Biophys. Res. Commun, 211: 205-210.